Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhasePendingDiscovery |
First Approval Date- |
Regulation- |
Molecular FormulaC25H27F3N6O2 |
InChIKeyHXKJJIMUMNPQQY-UHFFFAOYSA-N |
CAS Registry1620820-12-3 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Neoplasms | Discovery | United States | 30 Jul 2014 | |
Neoplasms | Discovery | United States | 30 Jul 2014 |